Status: Recruiting
Real-world Evaluation of the Effectiveness of Immunoglobulin-Histamine Complex, IHC (Histoglob) in Chronic Urticaria
This is a prospective, multicentre, non-interventional, observational, real-world evidence (RWE) study designed to evaluate the effectiveness and safety of Immunoglobulin/Histamine Complex (IHC) in patients with Chronic Urticaria in India.
Participants needed: 600
Trial details
Age: 13+Biological sex: AllType: ObservationalSponsor: Bharat Serums and Vaccines LimitedUpdated: Jul 2, 2026Locations: 40
Eligibility criteria
Male or female patients aged ≥13 years. [+3]
Known allergy or hypersensitivity to Histoglob or human immunoglobulin product. [+5]